An analysis of 2 pharmacovigilance databases revealed a high prevalence of azacitidine-related adverse events in patients with MDS or AML.

in the aggressive haematological malignancies of acute myeloid leukemia (AML) and MDS. The primary objective is to determine the safety and tolerability of bexmarilimab in combination with SoC ...

Metformin, a widely used and affordable diabetes drug, could prevent a form of acute myeloid leukemia in people at high risk ...

Changes in Blood Cell Production Over the ... the human lifetime could have implications for the treatment of acute myeloid leukemia and ... How Breast Cancer Cells Survive in Bone Marrow After ...

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains ...

A new study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.

Fms-like tyrosine kinase 3 (FLT3) is one of the most commonly mutated genes in acute myeloid leukemia (AML). FLT3 internal tandem duplication (ITD) plays an important role in shaping the clinical ...

MEMPHIS, Tenn. - The jury for the murder trial of Tyre Nichols will be selected from Davidson County, according to Shelby County District Attorney Steve Mulroy. Mulroy shared new details of the ...

Timing out storm chances and the Easter Weekend forecast here. Read more. Mild Thursday and Friday Showers/storms Thursday night and Friday More rain Easter Sunday PLANNING THE NEXT 24 HOURS ...

IF YOU DO NOT AGREE WITH ANY OF THE TERMS, PLEASE DO NOT USE THIS SITE. Please review the Terms regularly. The Terms may change at any time. By using the Site after a change in the Terms, you agree to ...

Potential treatments need to be subject to the highest standards of safety and efficacy. Transplanting dopamine-releasing neurons into the brain is a promising regenerative therapy for Parkinson ...